Dr. Reddy's Labs Receives FDA Form 483

  Published 10 months ago

Dr. Reddy's Laboratories' Miryalaguda API facility in India underwent a US FDA GMP inspection (May 19-24, 2025), resulting in a Form 483 with two observations. The company plans to address them promptly.

  • FDA inspected Dr. Reddy’s Miryalaguda facility.
  • Form 483 issued with 2 observations.
  • The company will address observations quickly.
You might like these

Adani Ports May 2025 Performance Surge

RateGain & Cloudbeds Unite AI for Hotel Growth

Go Digit Q1 Profit Jumps 37% YoY

India Eases Clean-Air Rules for Plants

Atal Pension Yojana Hits 8 Cr Mark

Jash Expands with New Plant Deal

Nifty, Sensex Slip on Bank Woes

News that matters the most ⚡